Extralymphatic virus sanctuaries as a consequence of potent T-cell activation-Reference-Cited by-同舟云学术

Extralymphatic virus sanctuaries as a consequence of potent T-cell activation

Published:2007-11 Issue:11 Volume:13 Page:1316-1323
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Recher Mike,Lang Karl S,Navarini Alexander,Hunziker Lukas,Lang Philipp A,Fink Katja,Freigang Stefan,Georgiev Panco,Hangartner Lars,Zellweger Raphael,Bergthaler Andreas,Hegazy Ahmed N,Eschli Bruno,Theocharides Alexandre,Jeker Lukas T,Merkler Doron,Odermatt Bernhard,Hersberger Martin,Hengartner Hans,Zinkernagel Rolf M

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm1670.pdf

Reference43 articles.

1. Hilleman, M.R. Strategies and mechanisms for host and pathogen survival in acute and persistent viral infections. Proc. Natl. Acad. Sci. USA 101 Suppl. 2, 14560–14566 (2004).

2. Peterlin, B.M. & Trono, D. Hide, shield and strike back: how HIV-infected cells avoid immune eradication. Nat. Rev. Immunol. 3, 97–107 (2003).

3. Alcami, A. Viral mimicry of cytokines, chemokines and their receptors. Nat. Rev. Immunol. 3, 36–50 (2003).

4. Wei, X. et al. Antibody neutralization and escape by HIV-1. Nature 422, 307–312 (2003).

5. Rehermann, B. & Nascimbeni, M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat. Rev. Immunol. 5, 215–229 (2005).

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Functional impairment of “helpless” CD8⁺memory T cells is transient and driven by prolonged but finite cognate antigen presentation;2024-01-26

2. The value of Interferon β in multiple sclerosis and novel opportunities for its anti-viral activity: a narrative literature review;Frontiers in Immunology;2023-06-02

3. AIDS virus-neutralizing antibody induction reciprocal to a PI3K gain-of-function disease;2023-04-21

4. Arenaviruses: Old viruses present new solutions for cancer therapy;Frontiers in Immunology;2023-03-24

5. Epstein–Barr virus and multiple sclerosis;Nature Reviews Microbiology;2022-08-05